Peter J. Schwartz
0000-0003-0367-1048
University of Milan
451 papers found
Refreshing results…
Letter concerning the editorial by Giustetto et al. Int J Cardiol 2018;254:170–171
A wearable remote monitoring system for the identification of subjects with a prolonged QT interval or at risk for drug-induced long QT syndrome
Cardiac arrest and Brugada syndrome: Is drug-induced type 1 ECG pattern always a marker of low risk?
Rationale and design of a prospective study to assess the effect of left cardiac sympathetic denervation in chronic heart failure
Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation
Founder populations with channelopathies and church records reveal all sorts of interesting secrets: Some are scientifically relevant
Cardiac sympathetic denervation 100 years later: Jonnesco would have never believed it
Functional Effects of Scn5a Channel Mutations and the Risk of Life-Threatening Events in Type 3 Long Qt Syndrome
Human Induced Pluripotent Stem Cells-Derived Cardiomyocytes Carrying CALM1-F142l Mutation Recapitulate LQTS Phenotype in Vitro
Symptomatic and Asymptomatic Discrimination by Single Nucleotide Polymorphisms in Lqts2 Patients: A Dna-Based Patient Stratification
Time, frequency and information domain analysis of heart period and QT variability in asymptomatic long QT syndrome type 2 patients
Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion) study
Single nucleotide polymorphisms discriminates between symptomatic and asymptomatic LQTS2 patients: A DNA-based patient classification
Detection of long QT syndrome in the community Reply
Genetic modifiers in the long QT3/Brugada overlap-syndrome caused by E1784K
Allelic variations in hERG expression discriminates between symptomatic and asymptomatic LQTS2 patient-hiPSC derived cardiomyocytes
Genome-Wide Association Analysis Identifies 3 Common Variants Predisposing to Brugada Syndrome, a Rare Disease with High Risk of Sudden Cardiac Death
FGF12 is a Novel Brugada Syndrome Locus
Novel Mutations in the Sodium Channel 2 Subunit Gene (SCN2B) Associated with Brugada Syndrome and Atrial Fibrillation
Antidepressants, QT interval and cardiovascular risk. Justified concerns? | Farmaci antidepressivi, intervallo QT e rischio cardiovascolare. Timori fondati?
Missing publications? Search for publications with a matching author name.